研究和商业化PI3K和AKT目标的发展:基于专利的景观
Hai-Long Zhang1, Zhaochen Lin2, Ying Zhang3
1Central International Intellectual Property (Baotou) Co. Ltd, Baotou, China.
Pharmaceutical patent analyst
|February 24, 2025
概括
对酸3-激酶 (PI3K) 和AKT信号通路的专利申请在20年内显著增长,主要用于抗癌疗法. 组合疗法是这些药物标的关键特征.
科学领域:
- 生物化学和分子生物学
- 药理学和药物发现
- 在瘤学瘤学.
背景情况:
- 氨基酸3-激酶 (PI3K) 和AKT信号通路与许多疾病有关.
- 这一途径代表了癌症和其他疾病的重要治疗标.
研究的目的:
- 分析过去二十年PI3K和AKT目标的专利格局.
- 确定PI3K和AKT药物开发中的关键治疗应用和趋势.
主要方法:
- 进行了全面的专利大数据分析.
- 与PI3K和AKT目标相关的专利被审查和分类.
主要成果:
- 在过去的20年中,对PI3K和AKT目标都观察到大量的专利申请.
- 抗癌疗法占两种目标专利的77%以上.
- 组合疗法是针对PI3K和AKT向药物的显著策略.
- 与AKT药物相比,PI3K向药物显示出更快的平均市场批准时间 (8.8年).
结论:
- PI3K和AKT信号通路是治疗研究和开发的高度活跃的领域.
- 专利数据强调了强烈关注抗癌应用和组合策略.
- 针对PI3K的药物显示出更快速获得市场批准的途径.
关键词:
在 AKT AKT 里面.在PI3K中,PI3K是指PI3K.抗癌药物 抗癌药物 抗癌药物大数据就是大数据.癌症 癌症 癌症 癌症 癌症药物 药物 药物 药物 药物 药物patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:54Protein Kinases and Phosphatases
13.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
01:42Phosphoinositides and PIPs
7.9K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.9K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K